Cara Therapeutics, Inc.

NASDAQ: CARA
$15.68
-$0.19 (-1.2%)
Closing price June 1, 2020
Cara Therapeutics shares were crushed on Tuesday after the firm announced results from its midstage trial in patients with chronic kidney disease.
Chris Lange